Royal Bank of Canada
FLNA

Royal Bank of Canada’s Filana Therapeutics FLNA Stock Holding History

Royal Bank of Canada’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3K Sell
1,553
-3,945
-72% -$8.12K ﹤0.01% 6616
2025
Q4 		$10K Sell
5,498
-67,741
-92% -$217K ﹤0.01% 6425
2025
Q3 		$213K Sell
73,239
-11,592
-14% -$26.7K ﹤0.01% 5053
2025
Q2 		$153K Buy
84,831
+83,754
+7,777% +$149K ﹤0.01% 5345
2025
Q1 		$1K Sell
1,077
-2,931
-73% -$7.4K ﹤0.01% 6707
2024
Q4 		$10K Sell
4,008
-4,107
-51% -$72.1K ﹤0.01% 6352
2024
Q3 		$239K Sell
8,115
-376
-4% -$8.66K ﹤0.01% 4672
2024
Q2 		$104K Buy
8,491
+4,025
+90% +$84.8K ﹤0.01% 5248
2024
Q1 		$90K Sell
4,466
-10,876
-71% -$251K ﹤0.01% 5246
2023
Q4 		$346K Buy
15,342
+6,137
+67% +$130K ﹤0.01% 4602
2023
Q3 		$153K Buy
9,205
+2,826
+44% +$56K ﹤0.01% 5044
2023
Q2 		$156K Buy
6,379
+551
+9% +$13.3K ﹤0.01% 4963
2023
Q1 		$140K Sell
5,828
-3,410
-37% -$94.5K ﹤0.01% 4897
2022
Q4 		$273K Buy
9,238
+4,886
+112% +$176K ﹤0.01% 4618
2022
Q3 		$183K Sell
4,352
-798
-15% -$21.6K ﹤0.01% 4844
2022
Q2 		$145K Sell
5,150
-432
-8% -$10.9K ﹤0.01% 5056
2022
Q1 		$208K Sell
5,582
-4,364
-44% -$185K ﹤0.01% 5051
2021
Q4 		$434K Buy
9,946
+5,262
+112% +$276K ﹤0.01% 4602
2021
Q3 		$291K Sell
4,684
-542
-10% -$45.2K ﹤0.01% 4803
2021
Q2 		$447K Buy
5,226
+2,774
+113% +$149K ﹤0.01% 4384
2021
Q1 		$110K Sell
2,452
-952
-28% -$37.4K ﹤0.01% 5394
2020
Q4 		$23K Sell
3,404
-2,639
-44% -$23.6K ﹤0.01% 6002
2020
Q3 		$70K Buy
6,043
+43
+0.7% +$194 ﹤0.01% 5178
2020
Q2 		$18K Buy
+6,000
New +$27.2K ﹤0.01% 5633
2020
Q1 		– Sell
-350
Closed -$2K – 6977
2019
Q4 		$2K Sell
350
-43
-11% -$74 ﹤0.01% 6570
2019
Q3 		$0 Hold
393
– – ﹤0.01% 7051
2019
Q2 		$0 Buy
393
+384
+4,267% +$435 ﹤0.01% 7133
2019
Q1 		$0 Hold
9
– – ﹤0.01% 7051
2018
Q4 		$0 Buy
+9
New +$10 ﹤0.01% 7062
2018
Q3 		– Sell
-7
Closed – – 6921
2018
Q2 		$0 Hold
7
– – ﹤0.01% 6726
2018
Q1 		$0 Hold
7
– – ﹤0.01% 6732
2017
Q4 		$0 Hold
7
– – ﹤0.01% 6831
2017
Q3 		$0 Buy
+7
New +$25 ﹤0.01% 6938
2016
Q4 		– Sell
-1,429
Closed -$10K – 6758
2016
Q3 		$10K Hold
1,429
– – ﹤0.01% 5788
2016
Q2 		$22K Hold
1,429
– – ﹤0.01% 5472
2016
Q1 		$22K Hold
1,429
– – ﹤0.01% 5450
2015
Q4 		$18K Buy
1,429
+1,386
+3,223% +$18.3K ﹤0.01% 5753
2015
Q3 		$1K Sell
43
-57
-57% -$719 ﹤0.01% 6507
2015
Q2 		$2K Buy
100
+57
+133% +$781 ﹤0.01% 6379
2015
Q1 		$1K Hold
43
– – ﹤0.01% 5992
2014
Q4 		$1K Hold
43
– – ﹤0.01% 6052
2014
Q3 		$1K Hold
43
– – ﹤0.01% 5877
2014
Q2 		$2K Hold
43
– – ﹤0.01% 5734
2014
Q1 		$2K Sell
43
-2
-4% -$71 ﹤0.01% 5738
2013
Q4 		$1K Buy
45
+2
+5% +$53 ﹤0.01% 5838
2013
Q3 		$1K Sell
43
-5
-10% -$87 ﹤0.01% 5970
2013
Q2 		$1K Buy
+48
New +$1.01K ﹤0.01% 5731

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Royal Bank of Canada's FLNA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Filana Therapeutics (FLNA) stake by 72% in Q1 2026, selling an estimated $8.12K and leaving 1,553 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #6616.

Royal Bank of Canada first reported a position in FLNA in Q2 2013 and has held it in 47 quarters since. The position peaked at $447K in Q2 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Royal Bank of Canada held 1,553 shares of Filana Therapeutics worth $3K as of Q1 2026.
  • Royal Bank of Canada sold 3,945 Filana Therapeutics shares in Q1 2026, an estimated $8.12K.
  • Filana Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6616 holding.
  • Royal Bank of Canada first reported a position in Filana Therapeutics in Q2 2013 and has held it in 47 quarters since.
  • Royal Bank of Canada's Filana Therapeutics position peaked at $447K in Q2 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.